Protective effects of vitamin C on cisplatin-induced renal damage: A light and electron microscopic study

Renal Failure

Volumn 30, Issue 1, 2008, Pages 1-8

  Tarladacalisir, Yeter Topcu ^a   Kanter, Mehmet ^a   Uygun, Muberra ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Morphometry; Nephrotoxicity; Rat; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTRON MICROSCOPY; GLOMERULUS; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; MITOCHONDRIAL MEMBRANE; MONONUCLEAR CELL; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCORBIC ACID; CISPLATIN; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; MALE; RATS; RATS, WISTAR;

EID: 38148999548     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701742070     Document Type: Article

References (48)

1. Antunes LM, Darin JD, Bianchi MD. Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol. Res. 2001;43:145-150.
2. Meyer KB, Madias NE. Cisplatin nephrotoxicity. Miner. Electrolyte. Metab. 1994;20:201-213.
3. Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: A dose-dependent study. Pharmacol. Res. 2000;41:405-411.
4. Vickers AEM, Rose K, Fisher R, Saulnier M, Sahota P, Bentley P. Kidney slices of human and rat to charactarize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol. 2004;32:577-590.
5. Durak I, Ozbek H, Karaayvaz M, Ozturk HS. Cisplatin induced acute renal failure by impairing antioxidant system in guinea pigs: Effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug Chem Toxicol. 2002;25:1-8.
6. Appenroth D, Frob S, Kertsen L, Splinter FK, Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch. Toxicol. 1997;71:677-683.
7. Saleh S, el-Demerdash E. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: Role of nitric oxide. Basic Clin Pharmacol Toxicol. 2005;97:91-97.
8. Blisard KS, Harrington DA. Toxicity of cis-diamminedichloroplatinum (II) (Cisplatin) in the frog, Rana pipiens. J. Comp. Pathol. 1990;103:387-398.
9. el-Shazly MO, Afify MM, el-Dieb MK. Histopathological study into side-effect toxicity of some drugs used in treatment of cancer. Arch Exp Veterinarmed. 1989;43:319-326.
10. Zhang J, Lindup E. Cisplatin nephrotoxicity: Decrease in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices. Biochem. Pharmacol. 1994;47:1127-1135.
11. Mistry P, Merazga Y, Spargo DJ, Riley PA, McBbrien DCH. The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother Pharmacol. 1991;28:277-282.
12. Sadzuka Y, Shoji T, Takino Y. Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem. Pharmacol. 1992;43:1872-1875.
13. Hannemann J, Baumann K. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology. 1988;51:119-132.
14. Sadzuka Y, Shoji T, Takino Y. Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats. Toxicol. Lett. 1992;62:293-300.
15. Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol. 1987;43:247-252.
16. Fukushi N, Gemba M. Use of cultured renal epithelial cells for the study of cisplatin toxicity. Jpn J Pharmacol. 1989;50:247-249.
17. Nishikawa M, Nagatomi H, Nishijima M, et al. Targeting superoxide dismutase to renal proximal tubule cells inhibits nephrotoxicity of cisplatin and increases the survival of cancer-bearing mice. Cancer Lett. 2001;171:133-138.
18. Sueishi K, Mishima K, Makino K, et al. Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur. J. Pharmacol. 2002;451:203-208.
19. Bompart G, Orfila C. Cisplatin nephrotoxicity in lead-pretreated rats: Enzymatic and morphological studies. Toxicol Lett. 1990;50:237-247.
20. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. Effects of lycopene againts cisplatin-induced nephrotoxicity and oxitadive stress in rats. Toxicology. 2005;212:116-123.
21. Olivero OA, Semino C, Kassim A, Lopez-Larraza DM, Pirier MC. Preferential binding of cisplatin to mitochondrial DNA of chinese hamster ovary cells. Mutat. Res. 1995;346:221-230.
22. Cilenti L, Kyriazis GA, Soundarapandian MM, et al. Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am. J. Physiol. Renal Physiol. 2005;288:371-379.
23. Tsao CS. An overview of ascorbic acid chemistry and biochemistry. In: Packer L, Fuchs J, eds. Vitamin C in Health and Disease. New York: Marcel Dekker; 1997:25-58.
24. Frei B, Stocker R, England L, Ames BN. Ascorbate: The most effective antioxidant in human blood plasma. Adv. Exp. Med Biol. 1990;264:155-163.
25. Halliwell B. vitamin C: Antioxidant or pro-oxidant in vivo? Free Radical Res. 1996;25:439-454.
26. Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J. 1999;13:1007-1023.
27. Padh H. Vitamin C: Newer insight into its biochemical functions. Nutr Rev. 1991;49:65-70.
28. Guinee DG, van Zee B, Houghton DC. Clinically silent progressive renal tubulointerstitial disease during cisplatin chemotherapy. Cancer. 1993;71:4050-4054.
29. Brady HR, Kone BC, Stromski ME, Zeidel ML, Giebisch G, Gullans SR. Mitochondrial injury: An early event in cisplatin toxicity to renal proximal tubules. Am J Physiol. 1990;258:1181-1187.
30. Kawai Y, Taniuchi S, Okahara S, Nakamura M, Gemba M. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation. Biol. Pharm. Bull. 2005;28:1385-1388.
31. Orfila C, Bompart G, Lepert JC, Suc JM, Girolami JP. Renal immunolocalization of kallikrein in cisplatin nephrotoxicity in rats. Histochem J. 1993;25:772-777.
32. Daugaard G, Abildgaard U. Cisplatin nephrotoxicity. Cancer Cemother. Pharmacol. 1989;25:1-9.
33. Kanaka C, Oetliker OH, Bianchetti MG. Chronic cisplatin tubulopahty in humans and animals: Clear-cut discrepant findings. Nephron. 1991;59:693.
34. Choie DD, Longnecker DS, del Campo AA. Acute and chronic nephropathy in rats. Lab. Invest. 1981; 44:397-402.
35. Mohan IK, Khan M, Shobha JC, et al. Protection against cisplatin-induced nephrotoxicity by spirulina in rats. Cancer Chemother. Pharmacol. 2006;58:802-808.
36. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner NW. Mechanism of cisplatinum nephrotoxicity II: Morphologic observations. J. Pharmacol. Exp. Ther. 1980;7:551-556.
37. Racusen LC, Solez R. Nephrotoxic tubular and interstitial lesions: Morphology and classification. Toxicol Pathol. 1986;14:45-49.
38. Herak-Kramberger CM, Sabolic I. The integrity of renal cortical brush-border and basolateral membrane vesicles is damaged in vitro by nephrotoxic heavy metals. Toxicology. 2001;156:139-147.
39. Gemba M, Fukuishi N. Amelioration by ascorbic acid of cisplatin-induced injury in cultured renal. Contrib Nephrol. 1991;95:138-142.
40. Sener G, Satiroglu H, Kabasakal L, et al. The protective effect of melatonin on cisplatin nephrotoxicity. Fundam Clin Pharmacol. 2000;14:553-560.
41. Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology. 2004;195:221-230.
42. Bogin E, Marom M, Levi Y. Changes in serum, liver and kidneys of cisplatin-trated rats: Effects of antioxidants. Eur J Clin Chem Clin Biochem. 1994;32:843-851.
43. Panayiotidis M, Collins AR. Ex vivo assesment of lymphocyte antioxidant status using the commet assay. Free Radical Res. 1997;27:533-537.
44. Blasiak J, Kowalik J. Protective action of vitamin C against DNA damage induced by selenium-cisplatin conjugate. Acta Biochim Pol. 2001;48:233-240.
45. Antunes LMG, Araújo MCP, Darin JDC, Bianchi MLP. Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells. Mutat. Res. 2000;465:131-137.
46. Jordan P, Carmo-Fonseca M. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci. 2000;57:1229-1235.
47. Block G, Henson DE, Levine M. vitamin C: A new look. Ann Intern Med. 1991;114:909-910.
48. Vissers MCM, Lee WG, Hampton MB. Regulation of apoptosis by vitamin C. J. Biol. Chem. 2001;276:46835-46840.